Technical Analysis for VBLT - Vascular Biogenics Ltd.
|Grade||Last Price||% Change||Price Change|
VBLT closed down 5.74 percent on Friday, January 18, 2019, on 63 percent of normal volume. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.
|Weak or Absent||Down||Up||Flat|
|See historical VBLT trend table...|
|Date||Alert Name||Type||% Chg|
|Jan 18||Bearish Engulfing||Bearish||0.00%|
|Jan 18||Stochastic Sell Signal||Bearish||0.00%|
|Jan 18||Outside Day||Range Expansion||0.00%|
|Jan 18||Wide Bands||Range Expansion||0.00%|
|Jan 18||Overbought Stochastic||Strength||0.00%|
|Jan 17||Narrow Range Bar||Range Contraction||-5.74%|
|Jan 17||NR7||Range Contraction||-5.74%|
|Jan 17||Wide Bands||Range Expansion||-5.74%|
|Jan 17||Overbought Stochastic||Strength||-5.74%|
|Jan 16||Wide Bands||Range Expansion||-4.17%|
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicatorsBasic chart:
Vascular Biogenics Ltd., a clinical-stage biopharmaceutical company, is engaged in the discovery, development, and commercialization of treatments for cancer and immune-inflammatory diseases. Its lead product candidates include VB-111, a gene-based biologic, which is in Phase II clinical trials for the treatment of recurrent glioblastoma, an aggressive form of brain cancer; in Phase II clinical trials to treat thyroid cancer; and in Phase I/II clinical trials for the treatment of ovarian cancer, as well as VB-201, an oral small molecule that is in Phase II clinical trials for the treatment psoriasis and ulcerative colitis. The company was formerly known as Medicard Ltd. and changed its name to Vascular Biogenics Ltd. in January 2003. Vascular Biogenics Ltd. was founded in 2000 and is headquartered in Or Yehuda, Israel.
|Indicator||Bull Case||Neutral / Hold||Bear Case|
|Oversold / Overbought|
|Summary:||Counts: 1 bullish, 2 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.|
See more VBLT news...
|52 Week High||7.6|
|52 Week Low||0.6|
|200-Day Moving Average||1.7404|
|50-Day Moving Average||1.1185|
|20-Day Moving Average||1.0155|
|10-Day Moving Average||1.154|
|Average True Range||0.099|
|Chandelier Exit (Long, 3 ATRs )||0.953|
|Chandelier Exit (Short, 3 ATRs )||0.897|
|Upper Bollinger Band||1.3487|
|Lower Bollinger Band||0.6823|
|Percent B (%b)||0.7|
|MACD Signal Line||-0.002|
|Market Cap||31.06 Million|
|Num Shares||27 Million|
|Price-to-Earnings (P/E) Ratio||-1.72|
|Pivot Point Level||Traditional / Classic||Fibonacci||Demark||Woodie||Camarilla|
|Resistance 4 (R4)||1.30|
|Resistance 3 (R3)||1.32||1.28||1.28|
|Resistance 2 (R2)||1.28||1.25||1.28||1.27|
|Resistance 1 (R1)||1.22||1.22||1.20||1.20||1.26|
|Support 1 (S1)||1.12||1.15||1.10||1.10||1.04|
|Support 2 (S2)||1.08||1.12||1.08||1.03|
|Support 3 (S3)||1.02||1.08||1.03|
|Support 4 (S4)||1.00|